C, L., M, S., N, S., JP, M., C, L., G, C., & J, M. (2025). Case Report: Successful treatment of metastatic retinoblastoma with CNS involvement with anti-GD2 immunotherapy, intrathecal topotecan and reduced systemic chemotherapy. Frontiers in pediatrics, 12, 1509645. https://doi.org/10.3389/fped.2024.1509645
Chicago Style (17th ed.) CitationC, Larrosa, Simao-Rafael M, Salvador N, Muñoz JP, Lavarino C, Chantada G, and Mora J. "Case Report: Successful Treatment of Metastatic Retinoblastoma with CNS Involvement with Anti-GD2 Immunotherapy, Intrathecal Topotecan and Reduced Systemic Chemotherapy." Frontiers in Pediatrics 12 (2025): 1509645. https://doi.org/10.3389/fped.2024.1509645.
MLA (9th ed.) CitationC, Larrosa, et al. "Case Report: Successful Treatment of Metastatic Retinoblastoma with CNS Involvement with Anti-GD2 Immunotherapy, Intrathecal Topotecan and Reduced Systemic Chemotherapy." Frontiers in Pediatrics, vol. 12, 2025, p. 1509645, https://doi.org/10.3389/fped.2024.1509645.